Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
AIM2 suppresses human breast cancer cell proliferation and mammary tumor growth
March 2nd, 2006
According to recent research from the United States, absent in melanoma 2 (AIM2) suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model. "IFN-inducible proteins are known to mediate IFN-directed antitumor effects. The human IFN-inducible protein AIM2 gene encodes a 39-kDa protein, which contains a 200-amino-acid repeat as a signature of HIN-200 family (hematopoietic IFN-inducible nuclear proteins)," wrote I.F. Chen and colleagues, M.D. Anderson Cancer Center. "Although AIM2 is known to inhibit fibroblast cell growth in vitro, its antitumor activity has not been shown. Here, we showed that AIM2 expression...
Source: Women's Health Weekly (2006-03-02)
|
